Evidence map›Paper›PMID 17389914›Full record

ArticlePloS one2007

Gene expression patterns in pancreatic tumors, cells and tissues.

Anson W Lowe, Mari Olsen, Ying Hao, Sum P Lee, Kyu Taek Lee, Xin Chen, Matt van de Rijn, Patrick O Brown

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Pancreatic Cancer: Genetic Conditions and Epigenetic Alterations.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Anson W LoweDepartment of Medicine, Stanford University Medical Center, Stanford, California, United States of America. lowe@stanford.edu
Mari Olsen
Ying Hao
Sum P Lee
Kyu Taek Lee
Xin Chen
Matt van de Rijn
Patrick O Brown
Stanford University · USHoward Hughes Medical Institute · USStanford Medicine · USSungkyunkwan University · KRUniversity of California, San Francisco · USVA Puget Sound Health Care System · US

Funding

GENE EXPRESSION IN CANCER BY MICROARRAY HYBRIDIZATIONR01CA077097 · NCI · STANFORD UNIVERSITY · PI BROWN, PATRICK O. · 1997 to 2010
$8.7M
NCI NIH HHS CA77097NCI NIH HHS R01 CA077097
6 · The paper itself

Abstract

backgroundCancers of the pancreas originate from both the endocrine and exocrine elements of the organ, and represent a major cause of cancer-related death. This study provides a comprehensive assessment of gene expression for pancreatic tumors, the normal pancreas, and nonneoplastic pancreatic disease. METHODS/

resultsDNA microarrays were used to assess the gene expression for surgically derived pancreatic adenocarcinomas, islet cell tumors, and mesenchymal tumors. The addition of normal pancreata, isolated islets, isolated pancreatic ducts, and pancreatic adenocarcinoma cell lines enhanced subsequent analysis by increasing the diversity in gene expression profiles obtained. Exocrine, endocrine, and mesenchymal tumors displayed unique gene expression profiles. Similarities in gene expression support the pancreatic duct as the origin of adenocarcinomas. In addition, genes highly expressed in other cancers and associated with specific signal transduction pathways were also found in pancreatic tumors.

conclusionThe scope of the present work was enhanced by the inclusion of publicly available datasets that encompass a wide spectrum of human tissues and enabled the identification of candidate genes that may serve diagnostic and therapeutic goals.

Indexed as

Gene Expression Regulation, NeoplasticAdenocarcinomaArtifactsAxin ProteinCarcinoma, Islet CellCell Line, TumorDNA, NeoplasmGene Expression ProfilingGenetic VariationHumansMultigene FamilyOligonucleotide Array Sequence AnalysisPancreasPancreatic NeoplasmsReference ValuesRepressor ProteinsAxin ProteinDNA, NeoplasmRepressor ProteinsRNA, Neoplasm

Identifiers

PMID17389914
PMCPMC1824711
OpenAlexW2055085803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.